Article Summaries
Emergency coronary artery bypass graft surgery in abciximab treated patients
Rapid platelet-function assay: an automated and quantitative cartridge-based method
Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques
Optimal management of bleeding and transfusion in patients undergoing cardiac surgery
Newer antiplatelet agents in acute coronary syndromes
Hemostatic agents and their safety
Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective
Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization. Management strategies for the cardiac surgeon
Clinical aspects of the use of clopidogrel, a new antiplatelet agent
Ticlopidine and clopidogrel
The emerging role of low-molecular-weight heparin and antiplatelet therapies in the cardiac catheterization laboratory
Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy
Bleeding complications of glycoprotein IIb-IIIa receptor inhibitors
Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors
Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?
Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease
Tirofiban. A review of its use in acute coronary syndromes
Abciximab and excessive bleeding in patients undergoing emergency cardiac operations
Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass
Reexploration for hemorrhage following coronary artery bypass
Platelet concentrate effects on thromboelastography
In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time
Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass
The effects of thrombocytopenia on the activated coagulation time
Desmopressin and bleeding during invasive surgery
Acquired von Willebrand's disease: a concise review
Reinfusion of mediastinal blood in CABG patients: impact on homologous transfusions and rate of re-exploration
Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations
